The development of a clinical prediction model for response to methotrexate, tofacitinib, and etanercept in patients with Psoriatic Arthritis. [PDF]
Perton FT +11 more
europepmc +1 more source
A case report: Guillain-Barré syndrome probably associated with TNF inhibitor in Blau syndrome. [PDF]
Han X +11 more
europepmc +1 more source
The Impact of 24-Month Etanercept Therapy on Changes in Adiponectin, Leptin and Tenascin C Levels in the Blood of Children with Juvenile Idiopathic Arthritis. [PDF]
Siwiec J +5 more
europepmc +1 more source
Assessing the repurposing potential of disease-modifying antirheumatic drug targets to reduce Alzheimer's disease risk: a Mendelian randomization study. [PDF]
Kushnir CN +3 more
europepmc +1 more source
Pharmacogenomic landscape of TNF inhibitors in the Middle Eastern Qatari population. [PDF]
Jan Z +4 more
europepmc +1 more source
Cost-Effectiveness Analysis of Recombinant Tumor Necrosis Factor Receptor: Fc Fusion Protein as First-Line Treatment for Active Rheumatoid Arthritis in China. [PDF]
Zhang R, Ma A.
europepmc +1 more source
Trends in immunomodulatory therapy for the treatment of chronic uveitis in the United States. [PDF]
Zhang C +4 more
europepmc +1 more source
Safety and Efficacy of Perispinal Etanercept for Chronic Stroke: A Randomized Clinical Trial. [PDF]
Thijs VN +12 more
europepmc +1 more source

